Abrdn Life Sciences Investors (HQL)

NYSE: HQL · Real-Time Price · USD

17.17

+0.01 (0.06%)

At close: Feb 3, 2026, 4:00 PM EST

17.25

+0.08 (0.47%)

After-hours: Feb 3, 2026, 6:25 PM EST

HQL Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	85.59	-	-	-	-
Loss (Gain) From Sale of Investments	-88.97	-	-	-	-
Other Operating Activities	35.29	-	-	-	-
Change in Accounts Receivable	0.06	-	-	-	-
Change in Other Net Operating Assets	-0.26	-	-	-	-
Operating Cash Flow	31.71	-	-	-	-
Common Dividends Paid	-31.63	-	-	-	-
Financing Cash Flow	-31.63	-	-	-	-
Net Cash Flow	0.08	-	-	-	-
Levered Free Cash Flow	-2.18	-	-	-	-
Unlevered Free Cash Flow	-2.18	-	-	-	-
Change in Working Capital	-0.2	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q